The first six months to a year, it's just uncomfortable because you feel you're still insecure, you're busting your a-- in the gym, you're not really seeing a big shift on the scale, but you got to keep going, the Revenge Body alum shared
Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater. Semaglutide and Its Impact on Weight Loss Several studies have been published looking at the effects of Semaglutide injections on weight loss: Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity This study which was published in 2022 looked at the effects of Semaglutide weekly 1.7-mg or 2.4-mg subcutaneous injections for 3 to 6 months
Just to catch anyone up who is unfamiliar with the term GLP-1 agonist, this term refers to a class of medications that all act on the GLP-1 receptor
Protective effects of leonurine hydrochloride on pyroptosis in premature ovarian insufficiency via regulating NLRP3/GSDMD pathway
Lauron S, Plasse C, Vaysset M et al (2023a) Prevalence and Odds of Depressive and anxiety disorders and symptoms in children and adults with alopecia areata: a systematic review and meta-analysis
